Press release - by TeraRecon, on Aug 2, 2023 12:13:01 PM
CAMBRIDGE, Mass., Aug. 2, 2023 /PRNewswire/ -- ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced today the integration of MiradaXD, the multi-modality nuclear medicine imaging software by Mirada Medical, into its AI partner program. This expands its ability to support cancer care providers with comprehensive oncology imaging solutions.
Mirada Medical's innovative software solutions, developed by world-leading experts in medical imaging, address a range of cancer-related challenges, from the automation of tumor segmentation and tracking to personalized treatment planning and response assessment. Mirada's toolset streamlines workflow enabling clinicians to efficiently, accurately and quickly identify cancerous and healthy anatomy for optimal diagnosis.
To find out more, see the full Press Release here